BiomX (PHGE) Short-term Investments (2018 - 2025)
BiomX (PHGE) posted Short-term Investments of $595000.0 for Q4 2025, down 39.59% sequentially from $985000.0 in Q3 2025, and down 37.89% YoY from $958000.0 in Q4 2024.
BiomX (PHGE) Short-term Investments (2018 - 2025) Analysis & Trends
BiomX has reported Short-term Investments for 8 years, with the latest figure at $595000.0 in Q4 2025.
- Quarterly Short-term Investments fell 37.89% year-over-year to $595000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $595000.0 (down 37.89% YoY) and the FY2025 annual result came in at $595000.0, down 37.89% from the prior year.
- Short-term Investments slipped to $595000.0 in Q4 2025 per PHGE's latest filing, from $985000.0 in the prior quarter.
- Over five years, Short-term Investments peaked at $8.0 million in Q2 2022 and troughed at $90000.0 in Q4 2022.
- A 5-year average of $1.4 million and a median of $977500.0 in 2021 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2022 and 2023: Short-term Investments slumped 90.96% in 2022, then jumped 963.33% in 2023.
- Over 5 years, Short-term Investments stood at $996000.0 in 2021, then plunged by 90.96% to $90000.0 in 2022, then surged by 963.33% to $957000.0 in 2023, then rose by 0.1% to $958000.0 in 2024, then slumped by 37.89% to $595000.0 in 2025.
- According to Business Quant data, Short-term Investments over the past three periods registered $595000.0, $985000.0, and $979000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BiomX | 351,774.34 | -816,225.66 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 595,000.00 |
| Sep 30, 2025 | 985,000.00 |
| Jun 30, 2025 | 979,000.00 |
| Mar 31, 2025 | 953,000.00 |
| Dec 31, 2024 | 958,000.00 |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 15, 2024 | 154,000.00 |
| Dec 31, 2023 | 957,000.00 |
| Sep 30, 2023 | 943,000.00 |
| Jun 30, 2023 | 951,000.00 |
| Mar 31, 2023 | 956,000.00 |
| Dec 31, 2022 | 90,000.00 |
| Sep 30, 2022 | 3.50 Mn |
| Jun 30, 2022 | 8.00 Mn |
| Mar 31, 2022 | 990,000.00 |
| Dec 31, 2021 | 996,000.00 |
| Sep 30, 2021 | 985,000.00 |
| Jun 30, 2021 | 982,000.00 |
| Mar 31, 2021 | 976,000.00 |